Vitamin C—An Adjunctive Therapy for Respiratory Infection, Sepsis and COVID-19
Holford et al.,
Vitamin C—An Adjunctive Therapy for Respiratory Infection, Sepsis and COVID-19,
Nutrients, doi:10.3390/nu12123760 (Review)
Review of vitamin C use for respiratory infections including COVID-19 and the mechanisms of action. Authors note that evidence to date indicates oral vitamin C (2–8 g/day) may reduce the incidence and duration of respiratory infections, and intravenous vitamin C (6–24 g/day) has been shown to reduce mortality, intensive care unit (ICU) and hospital stays, and time on mechanical ventilation for severe respiratory infections. Authors conclude that given the favourable safety profile and low cost of vitamin C, and the frequency of vitamin C deficiency in respiratory infections, it may be worthwhile testing patients’ vitamin C status and treating them accordingly with intravenous administration within ICUs and oral administration in hospitalised COVID-19 patients.
Holford et al., 7 Dec 2020, peer-reviewed, 7 authors.
Abstract: nutrients
Review
Vitamin C—An Adjunctive Therapy for Respiratory
Infection, Sepsis and COVID-19
Patrick Holford 1, *, Anitra C. Carr 2 , Thomas H. Jovic 3,4 , Stephen R. Ali 3,4 , Iain S. Whitaker 3,4 ,
Paul E. Marik 5 and A. David Smith 6
1
2
3
4
5
6
*
Institute for Optimum Nutrition, Ambassador House, Richmond TW9 1SQ, UK
Nutrition in Medicine Research Group, Department of Pathology & Biomedical Science, University of Otago,
Christchurch 8140, New Zealand; anitra.carr@otago.ac.nz
Reconstructive Surgery & Regenerative Medicine Research Group, Institute of Life Sciences,
Swansea University Medical School, Swansea University, Swansea SA2 8PY, UK;
Thomas.Jovic@wales.nhs.uk (T.H.J.); Stephen.Ali@wales.nhs.uk (S.R.A.);
Iain.Whitaker@wales.nhs.uk (I.S.W.)
Welsh Centre for Burns & Plastic Surgery, Morriston Hospital, Swansea SA6 6NL, UK
Division of Pulmonary and Critical Care Medicine, Eastern Virginia Medical School,
Norfolk, VA 23507, USA; marikpe@evms.edu
Department of Pharmacology, University of Oxford, Oxford OX1 3QT, UK; david.smith@pharm.ox.ac.uk
Correspondence: pat@patrickholford.com; Tel.: +44-(0)-7944-689108
Received: 19 October 2020; Accepted: 3 December 2020; Published: 7 December 2020
Abstract: There are limited proven therapies for COVID-19.
Vitamin C’s antioxidant,
anti-inflammatory and immunomodulating effects make it a potential therapeutic candidate, both for
the prevention and amelioration of COVID-19 infection, and as an adjunctive therapy in the critical
care of COVID-19. This literature review focuses on vitamin C deficiency in respiratory infections,
including COVID-19, and the mechanisms of action in infectious disease, including support of the
stress response, its role in preventing and treating colds and pneumonia, and its role in treating
sepsis and COVID-19. The evidence to date indicates that oral vitamin C (2–8 g/day) may reduce the
incidence and duration of respiratory infections and intravenous vitamin C (6–24 g/day) has been
shown to reduce mortality, intensive care unit (ICU) and hospital stays, and time on mechanical
ventilation for severe respiratory infections. Further trials are urgently warranted. Given the
favourable safety profile and low cost of vitamin C, and the frequency of vitamin C deficiency in
respiratory infections, it may be worthwhile testing patients’ vitamin C status and treating them
accordingly with intravenous administration within ICUs and oral administration in hospitalised
persons with COVID-19.
Keywords: COVID-19; SARS-CoV-2; coronavirus; vitamin C; ascorbate; colds; pneumonia; sepsis;
immunonutrition; supplementation
Please send us corrections, updates, or comments. Vaccines and
treatments are complementary. All practical, effective, and safe means should
be used based on risk/benefit analysis. No treatment, vaccine, or intervention
is 100% available and effective for all current and future variants. We do not
provide medical advice. Before taking any medication, consult a qualified
physician who can provide personalized advice and details of risks and
benefits based on your medical history and situation.
FLCCC and
WCH
provide treatment protocols.
Submit